Author pages are created from data sourced from our academic publisher partnerships and public sources.
Class of antiretroviral drugs and the risk of myocardial infarction.
- N. Friis-Møller, P. Reiss, +10 authors J. Lundgren
- The New England journal of medicine
- 26 April 2007
BACKGROUND We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according… Expand
Combination antiretroviral therapy and the risk of myocardial infarction.
- N. Friis-Møller, C. Sabin, +12 authors J. Lundgren
- Medicine, Biology
- The New England journal of medicine
- 20 November 2003
BACKGROUND It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. METHODS In this prospective observational study, we… Expand
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-infected persons, and to investigate any association between such risk factors, stage of HIV disease,… Expand
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
Despite recent advances in the management of hepatitis and HIV co-infection, there is no clear consensus among hepatology, infectious diseases and virology experts on treatment of co-infections and… Expand
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.
CONTEXT Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART), but evidence… Expand
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
- E. Arrivé, M. Newell, +7 authors F. Dabis
- International journal of epidemiology
- 1 October 2007
BACKGROUND Single-dose nevirapine (NVP) is the main option for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in countries with limited resources. However, the use of single-dose NVP… Expand
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
Objective:To estimate the prognosis over 5 years of HIV-1-infected, treatment-naive patients starting HAART, taking into account the immunological and virological response to therapy. Design:A… Expand
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.
- Y. Lévy, C. Lacabaratz, +13 authors J. Delfraissy
- The Journal of clinical investigation
- 1 April 2009
HIV infection results in CD4+ T cell deficiency, but efficient combination antiretroviral therapy (c-ART) restores T cells and decreases morbidity and mortality. However, immune restoration by c-ART… Expand
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
- N. Friis-Møller, R. Thiébaut, +11 authors M. Law
- European journal of cardiovascular prevention and…
- 1 October 2010
Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore,… Expand
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study
Objective:To investigate any emerging trends in causes of death amongst HIV-positive individuals in the current cART era, and to investigate the factors associated with each specific cause of death.… Expand